Page 62 - ANAESTHESIA_ABSTRACT_BOOK
P. 62

    ΒΙΒΛΙΟΓΡΑΦΙΑ
ΠΕΡΙΛΉΨΕΙΣ ΟΜΙΛΙΏΝ
ΣΥΝΕΔΡΙΑ 14
TIVA Η ΕΙΣΠΝΕΌΜΕΝΗ ΑΝΑΙΣΘΗΣΙΑ
1. Sung H, Ferlay J, Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185Countries. CA Cancer J Clin 2021; 71:209-249.
2. https://gco.iarc.fr/tomorrow/en/dataviz/isotype
3. https://gco.iarc.fr/today/data/factsheets/populations/300-greece-fact-sheets.pdf
4. Sullivan R, Alatise OI, Anderson BO et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol 2015; 16:1193–224.
5. Tohme S, Simmons RL, Tsung A. Surgery for Cancer: A Trigger for Metastases. Cancer Res. 2017 Apr 1; 77(7):1548-1552.
6. Demicheli R, Retsky MW, Hrushesky WJ et al. The effects of surgery on tumor growth: a century of investigations. Ann Oncol. 2008 Nov; 19(11):1821-8.
7. Cassinello F, Prieto I, del Olmo M et al. Cancer surgery: how may anesthesia influence outcome? J Clin Anesth. 2015 May; 27(3):262-72.
8. Vasileiou I, Xanthos T, Koudouna E et al. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol. 2009 Mar 1; 605(1-3):1-8.
9. Irwin MG, Chung CKE, Ip KY, Wiles MD. Influence of propofol-based total intravenous anaesthesia on peri-operative outcome measures: a narrative review. Anaesthesia. 2020 Jan; 75 Suppl 1:e90-e100.
10. Jiang S, Liu Y, Huang L et al. Effects of propofol on cancer development and chemotherapy: Potential mechanisms. Eur J Pharmacol. 2018 Jul 15; 831:46- 51.
11. Pandit JJ, Andrade J, Bogod DG, et al. 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. BJA 2014; 113: 549–59.
12. Gao Χ, Mi Υ, Guo Ν et al. The mechanism of propofol in cancer development: An updated review. Asia Pac J Clin Oncol. 2020 Apr; 16(2):e3-e11.
13. Ren XF, Li WZ, Meng FY, Lin CF. Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia. 2010; 65:478-482.
14. Dang Υ, Shi Χ, Xu W, Zuo M. The Effect of Anesthesia on the Immune System in Colorectal Cancer Patients. Can J Gastroenterol Hepatol. 2018 Apr 1; 2018:7940603.
15. Melamed R, Bar-Yosef S, Shakhar G et al. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003, 97:1331–1339.
16. Li R, Liu H, Dilger JP, Lin J. Effect of Propofol on breast Cancer cell, the immune system, and patient outcome. BMC Anesthesiology (2018) 18:77.
17. Cho JS, Lee MH, Kim SI et al. The effects of perioperative anesthesia and analgesia on immune function in patients undergoing breast cancer resection: a prospective randomized study. Int J Med Sci.2017; 14(10):970–6.
18. Lim JA, Oh CS, Yoon TG et al. The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery: an in vitro analysis. BMC Cancer. 2018 Feb 7; 18(1):159.
19. Ramirez MF, Cata JP. Anesthetic care influences long-term outcomes: What is the evidence? Best Pract Res Clin Anaesthesiol, available online 3 February 2021.
20. Hiller JG, Perry NJ, Poulogiannis G et al. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018 Apr; 15(4):205-218.
21. Huang H, Benzonana LL, Zhao H, et al. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br J Cancer. 2014; 111:1338–1349.
22. Markovic-Bozic J, Karpe Β, Potocnik I et al. Effect of propofol and sevoflurane on the inflammatory response of patients undergoing craniotomy. BMC Anesthesiol. 16, 18 (2016).
23. Li X, Li L, Liang F et al. Anesthetic drug propofol inhibits the expression of interleukin-6, interleukin-8 and cyclooxygenase-2, a potential mechanism for propofol in suppressing tumor development and metastasis. Oncol Lett. 2018 Jun; 15(6):9523-9528.
24. Meng C, Song L, Wang J et al. Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231. Oncol Rep. 2017; 37(2):841–8.
25. Yap A, Lopez-Olivo MA, Dubowitz J, et al. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth 2019; 66(5):546e61.
26. Chang CY, Wu MY, Chien YJ et al. Anesthesia and Long-term Oncological Outcomes: A Systematic Review and Meta-analysis. Anesth Analg. 2021 Mar 1; 132(3):623-634.
27. Dubowitz J, Hiller J, Riedel B. Anesthetic technique and cancer surgery outcomes. Curr Opin Anaesthesiol. 2021 Jun 1; 34(3):317-325. 28. Cata, JP, Sood AK, Eltzschig HK. Anesthetic Drugs and Cancer Progression. Anesthesiology. 2020 Oct 1; 133 (4):698-699.
29. Hasselager RP, Hallas J, Gögenur I. Inhalation or total intravenous anaesthesia and recurrence after colorectal cancer surgery: a propensity score matched Danish registry-based study. Br J Anaesth. 2021 May; 126(5):921-930.
30. Cata JP, Guerra C, Soto G, Ramirez MF. Anesthesia Options and the Recurrence of Cancer: What We Know so Far? Local Reg Anesth. 2020; 13:57-72.
 62
    
































































   60   61   62   63   64